Cargando…
Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
Autores principales: | Kohli-Pamnani, Anita, Zapata, Kristen, Gibson, Tiffany, Kwittken, Pamela L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413483/ https://www.ncbi.nlm.nih.gov/pubmed/34487840 http://dx.doi.org/10.1016/j.anai.2021.08.417 |
Ejemplares similares
-
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022) -
Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing?
por: Greenhawt, Matthew
Publicado: (2022) -
Non–immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol
por: Jiang, Shirley Y., et al.
Publicado: (2021) -
New allergy drug excipient allergy
por: Shah, Vipulkumar
Publicado: (2014) -
Cough, coronavirus disease 2019, the vaccines, and allergy
por: Chang, Yoon-Seok
Publicado: (2021)